6505--Bupropion Tablets
ID: 36E79724R0029Type: Presolicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNAC PHARMACEUTICALS (36E797)HINES, IL, 60141, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/d34816f002874a76a21a419569ea1c7c/view
Timeline
    Description

    The Department of Veterans Affairs (VA) is soliciting proposals for the procurement of Bupropion Hydrochloride tablets to support veterans and related entities through its Pharmaceutical Prime Vendor (PPV) Programs. Offerors are required to submit pricing that includes a 0.5% Cost Recovery Fee and provide unique National Drug Code (NDC) numbers for their products, while ensuring compliance with the Drug Supply Chain Security Act (DSCSA) and FDA regulations. This procurement is crucial for maintaining a reliable pharmaceutical supply for VA healthcare facilities, with a strong emphasis on participation from small and disadvantaged businesses. Interested parties should contact Contract Specialist Andrew J. Cazares at Andrew.Cazares@va.gov for further details regarding submission requirements and deadlines.

    Point(s) of Contact
    Andrew CazaresContract Specialist
    (719) 786-4990
    Andrew.Cazares@va.gov
    Files
    Title
    Posted
    _rels/.rels
    [Content_Types].xml
    36E79724R0029_1.docx
    The Department of Veterans Affairs (VA) National Acquisition Center is preparing to issue a Request for Proposal (RFP) numbered 36E79724R0029 for the procurement of Bupropion Hydrochloride (HCL) Tablets. This procurement ensures a consistent supply of these medications for various federal institutions, including the VA, Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The contract will last one year with an option for four additional years. Offerors must provide unique product labels and National Drug Code (NDC) numbers for the items supplied. Expected annual usage indicates a need for over 158,000 bottles of Bupropion tablets in different dosages. The proposal’s electronic solicitation is scheduled for release around September 16, 2024, with a submission deadline of September 30, 2024. Interested participants must regularly check the SAM.gov website for updates, as no paper copies will be distributed. Andrew Cazares serves as the primary point of contact for inquiries related to this procurement process. The notice emphasizes the VA's commitment to uninterrupted access to necessary pharmaceuticals for veterans and other eligible entities.
    36E79724R0029.docx
    The document outlines a solicitation from the Department of Veterans Affairs (VA) for the procurement of Bupropion Hydrochloride tablets to serve veterans and related entities through the Pharmaceutical Prime Vendor (PPV) Programs. It specifies the required quantities for both the base year and four option years. Offerors must submit prices that include a 0.5% Cost Recovery Fee, alongside unique National Drug Code (NDC) numbers specific to their products. The solicitation details necessary compliance with the Drug Supply Chain Security Act (DSCSA) and mandates that all products comply with FDA regulations and Good Manufacturing Practices (cGMP). The document also emphasizes the need for offerors to provide Letters of Commitment from manufacturers if they are not the producers, as well as demonstrating compliance with Federal Acquisition Regulation (FAR) requirements related to contract submissions. Additionally, the structure includes sections on contract clauses, requirements for manufacturing facilities, product registration, packaging, and barcode labeling. This solicitation reflects the VA's commitment to ensuring reliable and compliant pharmaceutical supply for its healthcare facilities while promoting participation from small and disadvantaged businesses.
    docProps/app.xml
    docProps/core.xml
    word/_rels/document.xml.rels
    word/document.xml
    word/fontTable.xml
    word/settings.xml
    word/styles.xml
    word/theme/theme1.xml
    word/webSettings.xml
    Lifecycle
    Title
    Type
    6505--Bupropion Tablets
    Solicitation
    6505--Bupropion Tablets
    Currently viewing
    Presolicitation
    Similar Opportunities
    6505--Lamotrigine Immediate Release (IR) Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting bids for the supply of Lamotrigine Immediate Release (IR) Tablets as part of its Pharmaceutical Prime Vendor (PPV) Program. The objective of this procurement is to establish a reliable supply source for these pharmaceuticals, ensuring their availability and implementing volume-based pricing for various government agencies, including the Department of Defense and Indian Health Services. Compliance with the Drug Supply Chain Security Act, stringent packaging requirements, and adherence to FDA cGMP standards are critical components of this contract, which includes a base year and four option years. Interested bidders should contact Contract Specialist Ray Roldan at Raymond.Roldan@va.gov for further details and to submit their proposals.
    6509--Warfarin Tablets (VA-25-00012328)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) 36E79725R0007 for the procurement of Warfarin Tablets, aimed at ensuring a reliable supply for various federal health agencies, including the Department of Defense and the Bureau of Prisons. This unrestricted procurement will cover multiple tablet strengths and packaging sizes, with an estimated annual usage detailed across 16 product types, and will be awarded for an initial one-year period with options for four additional years. The successful contractor must provide unique labeling and a National Drug Code (NDC) associated with their product, emphasizing the importance of compliance with federal regulations in pharmaceutical supply. Interested vendors should note that the solicitation will be electronically issued around November 13, 2024, with a response deadline of November 27, 2024; inquiries can be directed to Contract Specialist Adrienne Albachiara at adrienne.albachiara@va.gov.
    6505--Verapamil Hydrochloride (HCL) Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) National Acquisition Center is issuing a presolicitation notice for Request for Proposal (RFP) 36E79725R0006 to procure Verapamil Hydrochloride (HCL) Tablets. This procurement aims to ensure an uninterrupted supply of the drug for various federal entities, including the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). The contract will have a duration of one year, with the potential for four additional one-year options, and the estimated annual requirements include specific dosages and quantities of the tablets. Interested vendors must submit their proposals by December 4, 2024, and are encouraged to check SAM.gov for updates regarding the solicitation. For inquiries, vendors can contact Contract Specialist Deborah Fassl at Deborah.Fassl@va.gov or by phone at 708-786-5894.
    6505-- Pegfilgrastim
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Pegfilgrastim, a critical pharmaceutical product, through its Pharmaceutical Prime Vendor (PPV) program. The objective of this solicitation is to establish a reliable supply chain for specified medications at competitive prices, while ensuring compliance with the Drug Supply Chain Security Act (DSCSA) and promoting small business participation. Pegfilgrastim is essential for patients undergoing chemotherapy, as it helps to stimulate the production of white blood cells, thereby reducing the risk of infection. Interested offerors must submit proposals that include unique National Drug Codes (NDCs), pricing for a base year and four optional renewal years, and details on compliance with safety standards. For further inquiries, contact Contract Specialist Matthew S. Poulin at Matthew.Poulin@va.gov.
    6505--Aspirin_Dipyridamole SA Capsules (VA-25-00011491)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is soliciting offers for the procurement of Aspirin 25MG/Dipyridamole 200MG Sustained Action Capsules under solicitation number VA-25-00011491. This procurement aims to ensure a reliable supply chain for pharmaceuticals critical to various governmental health agencies, including the Department of Defense and Indian Health Services, and requires offerors to submit pricing for a base year and four option years, along with a Cost Recovery Fee of 0.5%. Compliance with the Drug Supply Chain Security Act (DSCSA) and FDA manufacturing standards is mandatory, and contractors must adhere to stringent packaging and labeling guidelines while demonstrating past performance evaluations. Interested parties should contact Contract Specialist Youlanda Duggar at youlanda.duggar@va.gov for further details.
    6505--Metformin SA Tablets REPACK PROGRAM
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Metformin HCL SA Tablets, aimed at ensuring a consistent supply for various governmental entities, including the VA, Department of Defense, Bureau of Prisons, and others. The procurement will cover a one-year contract with the possibility of four additional one-year extensions, requiring offerors to provide a unique National Drug Code (NDC) number and distinct labeling for the supplied products. This initiative is critical for maintaining the availability of essential pharmaceuticals, with estimated annual requirements detailed for two groups: Other Government Agencies and the VA Repack Program. The solicitation, numbered 36E79725R0003, is scheduled for electronic release on December 3, 2024, with a closing date of December 17, 2024. Interested parties can direct inquiries to Teresa Hussain at teresa.hussain@va.gov or by phone at 708-786-5852, and are encouraged to monitor SAM.gov for updates.
    6505--Abiraterone Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for Request for Proposal (RFP) 36E79725R0005 to procure Abiraterone Acetate Tablets, an essential medication for various federal health care programs. The procurement aims to secure a reliable supply of 250mg Abiraterone Acetate Tablets, with an estimated annual requirement of 71,997 bottles, to support the VA, Department of Defense, Bureau of Prisons, and other federal entities. This contract will span one base year with four optional one-year extensions, ensuring continuity of supply for critical health services. Interested offerors should monitor sam.gov for the electronic issuance of the solicitation on or about November 22, 2024, with a closing date of December 6, 2024; inquiries can be directed to Richard Mahario at Richard.Mahario@va.gov or by phone at 708-786-5247.
    6505--770-25-1-801-0019 -National CMOP BUDESONIDE -(VA-25-00010963)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Budesonide 0.5MG/2ML inhalation suspension through the National CMOP program. Vendors are required to submit a signed SF1449 solicitation cover page, a completed quote spreadsheet, evidence of a valid state wholesale distributor license, and a Trade Agreement Act certificate, with all submissions due by November 8, 2024. This pharmaceutical is critical for the treatment of respiratory conditions among veterans, and all products must comply with stringent regulatory standards, including bar-coding and adherence to the Drug Supply Chain Security Act. Interested vendors can contact Contract Specialist Kelley Cunningham at kelley.cunningham@va.gov for further details.
    6505--Omeprazole Dr Capsules- NAC Repack
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) National Acquisition Center is preparing to issue a Request for Proposal (RFP) 36E79725R0002 for the procurement of Omeprazole DR Capsules, aimed at supporting various health service agencies, including the VA, Bureau of Prisons, and others. This unrestricted procurement will award one contract per group, with a total contract duration of one year and the potential for four additional one-year option periods. The procurement is critical for ensuring a reliable supply of essential medications, with specific packaging requirements including safety caps and unique NDC numbers for the products. Interested offerors should note that the solicitation is expected to be released electronically on or around November 19, 2024, with a closing date of December 3, 2024. For further inquiries, interested parties can contact Teresa Hussain at teresa.hussain@va.gov or by phone at 708-786-5852.
    6505--S0578 SEVELAMER CARBONATE 800MG TAB (VA-25-00008856)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified vendors to procure Sevelamer Carbonate 800mg tablets for delivery to multiple Consolidated Mail Outpatient Pharmacy (CMOP) facilities. The procurement aims to ensure an adequate supply of this essential pharmaceutical, which plays a critical role in the healthcare of veterans, with a total requirement of 8,480 tablets across various locations including Leavenworth, Chelmsford, Tucson, Dallas, Murfreesboro, Great Lakes, and Charleston. Interested parties must submit their quotations by October 31, 2024, including a signed SF1449 cover page, a completed pricing schedule, a valid State Wholesale Distributor License, and a Trade Agreements Act certificate, with all submissions directed to Contract Specialist Kelley Cunningham at kelley.cunningham@va.gov.